Bryan Johnson· Author
Treatment with anti-IL-11 from 75 weeks of age until death extends the median lifespan of male mice by 22.5% and of female mice by 25%.
Loading…
The evidence is convergent. Multiple independent sources reach the same conclusion, the underlying mechanism is well-characterized, and even the field's most cautious voices treat it as worth doing.
Treatment with anti-IL-11 from 75 weeks of age until death extends the median lifespan of male mice by 22.5% and of female mice by 25%.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Removal of interleukin-11 improves health and extends mouse lifespan by up to 24%.
you could imagine this to become part of the whole armamentarium that we have against aging.
uh yes and they're actually recently was contacted by a company that has another uh novel inhibitors of of IL11 you could imagine this to become part of the whole armamentarium that we have against aging.
big trial last fall that looked at blocking interlucan 11 which is a molecule that's made by immune cells plays an important role in inflammation. Um, and this was done in mice and those mice lived longer.
Big trial last fall that looked at blocking interlucan 11 which is a molecule that's made by immune cells plays an important role in inflammation. And this was done in mice and those mice lived longer.